Poster Presentations

Thursday, March 12 – Friday, March 13 ,2009

• Alzheimer's Disease (AD) including Non-Cognitive Aspects
• Parkinson's Disease (PD), PD Dementia, Atypical PD & Non Motor Symptoms in PD
• Epidemiology, Pharmacoeconomics and Quality of Life
• Neuroimaging
• Biomarkers and Diagnostics in Prevention and Treatment
• Biology of Amyloid Precursor Protein (APP) and ß-Amyloid; Generation and Turnover of ß-Amyloid
• TAU, Cytoskeleton and Tauopathies
• Apolipoprotein-E
• Animal Models of Neurodegenerative Diseases and Disorders
• Modulation of Secretases
• Modulation of Kinases and Phosphatases
• Neurotransmitter-Based
• Cholesterol and Lipids
• Novel Pharmacological Compounds
• Novel Biological Agents
• Drug Discovery and Development
• Genetics of Neurodegenerative Diseases and Disorders

Friday, March 14 – Saturday, March 15, 2009

• Alzheimer's Disease (AD) including Non-Cognitive Aspects
• Parkinson's Disease (PD), PD Dementia, Atypical PD & Non Motor Symptoms in PD
• Minimal Cognitive Impairment (MCI) and Age-Associated Memory Impairment (AAMI)
• Vascular Dementia (VAD)
• Cerebral Amyloid Angiopathy (CAA)
• Dementia with Lewy Bodies (DLB)
• Frontotemporal Dementia (FTD)
• Movement Disorders other than PD (Tics, Restless Legs Syndrome, Dystonia)
• Depression and Psychotic States in AD/PD
• Neurodevelopment and Neurodegeneration
• Head Injury
• Cognitive Impairments in Autoimmune Disorders
• Amyotrophic Lateral Sclerosis (ALS) and Huntington's Disease (HD)
• Multiple Systems Atrophy
• Progranulinopathies and other Protein Misfolding Diseases (PMD)
• Biomarkers and Diagnostics in Prevention and Treatment
• CNS-Periphery Communication in Neurodegenerative Diseases and Disorders
• Energy Metabolism and Oxidative Stress
• Inflammation
• Synucleopathies
• Animal Models of Neurodegenerative Diseases and Disorders
• Aggregation Inhibitors
• Low Molecular Weight Glycosaminoglycans (GAGs) and GAG-Mimetics
• Neurotrophic Factors and Inhibitors
• Immunotherapies and Antibodies
• Stem Cells
• Gene Therapies
• New Drug Delivery Systems / Methods
• Neurotransplantation and Neurosurgery
• Novel Pharmacological Compounds